Source: GWASCAT
Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
zinc finger E-box binding homeobox 2 | 0.471 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
calpain 15 | 0.890 | 0.077 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2013 | 2013 | ||||||||
|
solute carrier family 20 member 2 | 0.638 | 0.577 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
solute carrier family 14 member 1 (Kidd blood group) | 0.678 | 0.538 | 5.8E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
Rh blood group CcEe antigens | 0.666 | 0.500 | 1.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
RAB40C, member RAS oncogene family | 0.839 | 0.308 | 1.5E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
arginine and serine rich protein 1 | 0.890 | 0.231 | 4.3E-14 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
otoraplin | 0.805 | 0.154 | 4.9E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
family with sequence similarity 222 member B | 0.29 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||||
|
LUC7 like | 0.861 | 0.115 | 0.47 |
|
phenotype | 0.100 | None | 1.000 | 1 | 2 | 2012 | 2016 | ||||||||
|
phosphoribosylformylglycinamidine synthase | 0.780 | 0.308 | 9.9E-18 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
3-hydroxyacyl-CoA dehydratase 3 | 0.861 | 0.154 | 9.3E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
solute carrier family 25 member 37 | 0.597 | 0.731 | 0.28 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
plasmolipin | 0.805 | 0.269 | 9.2E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
olfactory receptor family 52 subfamily K member 3 pseudogene |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | |||||||||||
|
small integral membrane protein 1 (Vel blood group) | 0.792 | 0.308 | 3.3E-02 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2016 | ||||||||
|
Spi-1 proto-oncogene | 0.631 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2019 | 2019 | ||||||||
|
spectrin beta, erythrocytic | 0.650 | 0.462 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
CD36 molecule | 0.446 | 0.846 | 1.1E-60 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2018 | 2018 | ||||||||
|
cyclin D3 | 0.554 | 0.654 | 0.98 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2017 | ||||||||
|
ZPR1 zinc finger | 0.674 | 0.462 | 8.9E-09 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||
|
RAB11A, member RAS oncogene family | 0.601 | 0.692 | 0.99 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2018 | ||||||||
|
protein phosphatase 1 regulatory subunit 16A | 4.4E-03 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2016 | 2016 | ||||||||||
|
HDGF like 2 | 0.722 | 0.269 | 0.77 |
|
phenotype | 0.100 | None | 1.000 | 1 | 1 | 2012 | 2016 |